Chondroitin Sulfate Market

Market Overview 2023-2028:

The global chondroitin sulfate market size reached US$ 1.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1.8 Billion by 2028, exhibiting a growth rate (CAGR) of 3.3% during 2023-2028.

Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C₆H₁₃NO₅) is anti-atherogenic, inflammatory, thrombogenic and assists in the performance of coagulant activities. Consequently, it is utilized in oral delivery of insulin, proteins and peptides and as a skin substitute and biomaterial for wound healing in the healthcare sector.

CS acts as a precursor for inhibiting degradation, stimulating synthesis and improving the healing of articular cartilage. This represents one of the primary factors escalating the demand for CS-based injectable hydrogels in cartilage tissue engineering for fabricating purposes. Moreover, as it is an enzymatically biodegradable polysaccharide and has high water solubility and lack of mechanical stability, CS is modified with materials like collagen to be utilized in scaffold matrices and other drug delivery applications. Furthermore, it is being used in dietary supplements for relieving pain and disability of individuals with musculoskeletal pathologies or osteoarthritis. In line with this, CS serves as a template for generating hydroxyapatite nanocrystals, thereby contributing to the market growth. It is also gaining traction as an antistatic agent in the cosmetics industry for manufacturing hair conditioning products.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global chondroitin sulfate market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on source, form and application.

Breakup by Source:

• Bovine
• Swine
• Poultry
• Shark
• Others
   

Breakup by Form:

• Powder
• Tablet
• Others
   

Breakup by Application:

• Pharmaceuticals and Nutraceuticals
• Animal Feed
• Personal Care and Cosmetics
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.

Report Coverage:

Key Questions Answered in This Report:

• How has the global chondroitin sulfate market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global chondroitin sulfate market?
• What are the key regional markets?
• What is the breakup of the market based on the source?
• What is the breakup of the market based on the form?
• What is the breakup of the market based on the application?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global chondroitin sulfate market and who are the key players?
• What is the degree of competition in the industry?